These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25391390)

  • 21. Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer.
    Kozu Y; Maniwa T; Takahashi S; Isaka M; Ohde Y; Nakajima T
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e53-8. PubMed ID: 23557919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection.
    Agarwal M; Brahmanday G; Chmielewski GW; Welsh RJ; Ravikrishnan KP
    Lung Cancer; 2010 Jun; 68(3):398-402. PubMed ID: 19762109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Port JL; Korst RJ; Lee PC; Kansler AL; Kerem Y; Altorki NK
    Ann Thorac Surg; 2007 Feb; 83(2):397-400. PubMed ID: 17257959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
    Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in stage III non-small-cell lung cancer.
    Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
    Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of 250 ten-year survivors after pneumonectomy for non-small-cell lung cancer.
    Riquet M; Mordant P; Pricopi C; Legras A; Foucault C; Dujon A; Arame A; Le Pimpec-Barthes F
    Eur J Cardiothorac Surg; 2014 May; 45(5):876-81. PubMed ID: 24132299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.
    Sato T; Watanabe A; Kondo H; Kanzaki M; Okubo K; Yokoi K; Matsumoto K; Marutsuka T; Shinohara H; Teramukai S; Kishi K; Ebina M; Sugiyama Y; Meinoshin O; Date H;
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):64-9, 70.e1-2. PubMed ID: 25439777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
    Almquist D; Khanal N; Smith L; Ganti AK
    Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Bugge AS; Lund MB; Valberg M; Brustugun OT; Solberg S; Kongerud J
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):221-227. PubMed ID: 28950311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer.
    Liu CY; Hung JJ; Wang BY; Hsu WH; Wu YC
    Eur Respir J; 2013 Mar; 41(3):649-55. PubMed ID: 22835612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
    Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
    Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.